跳至主要内容
临床试验/CTRI/2021/11/038136
CTRI/2021/11/038136尚未招募未知

Evaluation of the role of N-acetyl cysteine (NAC) in Novel Corona Virus infection (COVID-19): A proof of concept study - COVINAC

Rajiv Gandhi University of Health Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Hospitalized adult age 18 to 70 years
  • 2.Laboratory-confirmed SARS-CoV-2 infection as determined by polymerase chain reaction (PCR) or other commercial or public health assay
  • 3.Moderate Covid-19 patients not requiring organ support
  • 4.Mild Covid requiring hospitalization
  • 5 Duration of Hospital less than 48 hours.

排除标准

  • 1. Unlikely to survive after 48 hours from screening or unlikely to remain at the investigational site beyond 48 hours
  • 2. Requiring organ support at screening (Organ support defined as need for ICU care, mechanical ventilation, Non Invasive Ventilation (NIV), High flow Nasal Oxygen at screening
  • 3. Participation in any other clinical trial of an experimental treatment for COVID-19
  • 4. Known hypersensitivity to the trial drug or its components
  • 5. Pregnant women or women who are breastfeeding
  • 6. Consideration by the investigator, for any reason, that the subject is an unsuitable candidate to receive study treatment
  • 7. Unable to provide consent

研究者

相似试验